Open AccessP32 Erlotinib in combination with different chemotherapeutics is active in a SCID mouse/human melanoma model
Author(s) -
Nikolaus Schicher,
Hubert Pehamberger,
Christoph Höeller
Publication year - 2010
Publication title -
melanoma research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.072
H-Index - 73
eISSN - 1473-5636
pISSN - 0960-8931
DOI - 10.1097/01.cmr.0000382865.19457.6a
Subject(s) - erlotinib , dacarbazine , medicine , bevacizumab , paclitaxel , pharmacology , chemotherapy , angiogenesis , oncology , cancer research , cisplatin , cancer , epidermal growth factor receptor